PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.


Journal

Reviews in endocrine & metabolic disorders
ISSN: 1573-2606
Titre abrégé: Rev Endocr Metab Disord
Pays: Germany
ID NLM: 100940588

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 23 3 2019
medline: 14 4 2020
entrez: 23 3 2019
Statut: ppublish

Résumé

A more conservative approach to the clinical management of thyroid nodules and differentiated thyroid cancer has recently been proposed by the 2015 ATA guidelines. In this context, fine-needle aspiration biopsy has been reserved for nodules with particular ultrasound features or dimensions that exclude low-risk thyroid lesions. Accordingly, a less aggressive surgical approach (i.e. lobectomy) has been recommended as the first-choice treatment in nodules with indeterminate cytology or in small cytologically confirmed malignant nodules. At the same time, radioactive remnant ablation has been considered only for DTC patients with concrete risks of disease persistence/relapse after thyroidectomy. In addition, further radioactive iodine therapies (RAI) have been proposed only for patients presenting unresectable and iodine-avid structural relapse. In this complex scenario, which requires attention to each clinical aspect of the patient, the introduction of accurate diagnostic tools is highly warranted. PET/CT is a very sensitive and specific diagnostic procedure that can better characterize the risk of thyroid nodules, identify DTC relapse early and predict the response to RAI. Thus, it seems essential to customize a more conservative approach to thyroid nodules and DTC patients. The aim of this review is to report the principal clinical context in which PET/CT has been used and to evaluate the evidence-based support for each diagnostic indication.

Identifiants

pubmed: 30900067
doi: 10.1007/s11154-019-09491-2
pii: 10.1007/s11154-019-09491-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

47-64

Références

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1107-16
pubmed: 22526958
J Clin Endocrinol Metab. 2014 Sep;99(9):3263-74
pubmed: 24873995
Nucl Med Commun. 2009 Sep;30(9):742-8
pubmed: 19561553
Endocr Relat Cancer. 2018 Jun;25(6):643-652
pubmed: 29559552
J Nucl Med. 2006 Aug;47(8):1260-6
pubmed: 16883003
Cancer. 2011 Oct 15;117(20):4582-94
pubmed: 21432844
Clin Endocrinol (Oxf). 2011 May;74(5):644-8
pubmed: 21470288
Nuklearmedizin. 2013;52(4):130-6
pubmed: 23765102
J Clin Endocrinol Metab. 2007 May;92(5):1630-4
pubmed: 17284624
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1622-3
pubmed: 25916744
Lancet Diabetes Endocrinol. 2014 May;2(5):356-8
pubmed: 24795243
Eur J Endocrinol. 2015 Apr;172(4):403-13
pubmed: 25583906
Tumour Biol. 2014 Jun;35(6):6139-47
pubmed: 24622887
Eur Arch Otorhinolaryngol. 2010 Jul;267(7):1019-26
pubmed: 20155360
J Clin Endocrinol Metab. 2006 Feb;91(2):498-505
pubmed: 16303836
Nucl Med Mol Imaging. 2018 Apr;52(2):154-158
pubmed: 29662564
Nucl Med Commun. 2009 Aug;30(8):639-50
pubmed: 19512954
Eur J Endocrinol. 2015 Sep;173(3):R115-30
pubmed: 25947140
Thyroid. 2012 Feb;22(2):165-72
pubmed: 22257371
Ann Surg Oncol. 2007 Nov;14(11):3210-5
pubmed: 17713821
Clin Oncol (R Coll Radiol). 2010 Aug;22(6):438-47
pubmed: 20561773
Int J Endocrinol. 2013;2013:856189
pubmed: 23653645
Eur J Endocrinol. 2010 Aug;163(2):177-83
pubmed: 20484385
Clin Endocrinol (Oxf). 2017 Nov;87(5):411-417
pubmed: 28666074
Pathologica. 2010 Oct;102(5):405-8
pubmed: 21361121
J Clin Endocrinol Metab. 2007 Nov;92(11):4485-8
pubmed: 17684046
J Nucl Med. 2003 Sep;44(9):1402-6
pubmed: 12960183
Diagn Cytopathol. 2009 Oct;37(10):783-5
pubmed: 19626631
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91
pubmed: 24781870
Clin Cancer Res. 2010 Nov 1;16(21):5260-8
pubmed: 20847059
Thyroid. 2012 Sep;22(9):918-25
pubmed: 22827552
World J Surg. 2010 Nov;34(11):2564-9
pubmed: 20645089
J Nucl Med. 2016 Sep;57(9):1339-42
pubmed: 27151981
Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8
pubmed: 18314022
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):874-80
pubmed: 23463330
Head Neck. 2012 May;34(5):626-31
pubmed: 21850699
Endocrine. 2015 Nov;50(2):335-43
pubmed: 25534701
J Nucl Med Technol. 2016 Sep;44(3):199-200
pubmed: 26966127
Endocrinol Metab Clin North Am. 2000 Mar;29(1):187-203
pubmed: 10732271
Q J Nucl Med Mol Imaging. 2009 Oct;53(5):536-45
pubmed: 19910907
Otolaryngol Head Neck Surg. 2014 Aug;151(2):190-200
pubmed: 24759908
Eur J Nucl Med Mol Imaging. 2013 May;40(5):693-700
pubmed: 23340593
Eur J Nucl Med Mol Imaging. 2008 May;35(5):950-7
pubmed: 18193222
Thyroid. 2012 Aug;22(8):832-8
pubmed: 22853728
Eur J Endocrinol. 2016 May;174(5):693-703
pubmed: 26966173
Lancet Oncol. 2007 Feb;8(2):148-56
pubmed: 17267329
J Clin Endocrinol Metab. 2010 Mar;95(3):1169-73
pubmed: 20080852
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):1995-2001
pubmed: 26173620
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1354-62
pubmed: 24562651
Sci Rep. 2017 Jul 12;7(1):5202
pubmed: 28701709
Cancer Med. 2016 Oct;5(10):2756-2762
pubmed: 27539659
Ann Nucl Med. 2012 Apr;26(3):207-13
pubmed: 22160654
Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):502-8
pubmed: 18026950
Thyroid. 2014 Sep;24(9):1394-9
pubmed: 24820222
Clin Endocrinol (Oxf). 2013 May;78(5):760-7
pubmed: 23009688
Clin Nucl Med. 2011 Feb;36(2):91-5
pubmed: 21220968
Clin Endocrinol (Oxf). 2006 Sep;65(3):402-7
pubmed: 16918964
Thyroid. 2016 Mar;26(3):441-8
pubmed: 26857905
J Nucl Med. 2016 May;57(5):701-7
pubmed: 26609180
J Nucl Med. 2005 Jul;46(7):1164-70
pubmed: 16000286
Eur Thyroid J. 2018 Jan;7(1):13-20
pubmed: 29594049
Thyroid. 2014 Apr;24(4):715-26
pubmed: 24102584
J Nucl Med. 2012 Mar;53(3):359-62
pubmed: 22315442
Curr Urol. 2017 Nov;10(4):217-220
pubmed: 29234267
Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1941-59
pubmed: 18670773
Clin Endocrinol (Oxf). 2015 Jul;83(1):124-32
pubmed: 25130203
Lancet Oncol. 2012 Sep;13(9):897-905
pubmed: 22898678
Head Neck. 2016 Feb;38(2):316-27
pubmed: 25251544
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1373-80
pubmed: 22718304
Clin Nucl Med. 2017 Jan;42(1):20-25
pubmed: 27846003
J Clin Oncol. 2009 Apr 1;27(10):1675-84
pubmed: 19255327
BMJ Open. 2018 Aug 30;8(8):e021001
pubmed: 30166292
Clin Nucl Med. 2012 Oct;37(10):953-9
pubmed: 22899202
Thyroid. 2002 Sep;12(9):747-54
pubmed: 12481939
Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S48-56
pubmed: 21484380
J Nucl Med. 2016 Oct;57(10):1512-1517
pubmed: 27033897
J Med Imaging Radiat Oncol. 2015 Jun;59(3):281-8
pubmed: 25676871
Endocr Rev. 2013 Jun;34(3):439-55
pubmed: 23575762
Ann Surg Oncol. 2010 Jan;17(1):115-22
pubmed: 19826877
Oncotarget. 2018 Jan 4;9(11):9867-9874
pubmed: 29515776
J Clin Endocrinol Metab. 2012 Nov;97(11):3866-75
pubmed: 22904176
Thyroid. 2017 Oct;27(10):1300-1306
pubmed: 28793848
Surgery. 2003 Mar;133(3):294-9
pubmed: 12660642
Endocrine. 2019 May;64(2):203-208
pubmed: 30637562
JAMA. 2013 Apr 10;309(14):1493-501
pubmed: 23571588
J Clin Endocrinol Metab. 2012 Apr;97(4):1250-7
pubmed: 22319042
J Ultrasound Med. 2011 Sep;30(9):1267-73
pubmed: 21876098
Endocrine. 2018 Dec;62(3):729-730
pubmed: 30091127
Q J Nucl Med Mol Imaging. 2011 Feb;55(1):57-65
pubmed: 21285923
J Nucl Med. 2006 May;47(5):770-5
pubmed: 16644746
Nucl Med Commun. 2011 Apr;32(4):245-51
pubmed: 21278616
Clin Endocrinol (Oxf). 2017 May;86(5):645-651
pubmed: 28160320
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Endocr Pract. 2018 Jan;24(1):21-26
pubmed: 29144823
Nuklearmedizin. 1995 Aug;34(4):127-34
pubmed: 7675641
Eur J Nucl Med Mol Imaging. 2008 May;35(5):958-65
pubmed: 18175115
Expert Rev Endocrinol Metab. 2012 Jan;7(1):35-43
pubmed: 30736109
Thyroid. 2012 Jul;22(7):725-9
pubmed: 22524470
World J Surg. 2010 Jun;34(6):1247-53
pubmed: 20140435
J Med Imaging Radiat Oncol. 2015 Jun;59(3):278-80
pubmed: 26053477
Q J Nucl Med Mol Imaging. 2010 Feb;54(1):76-83
pubmed: 20168289
Thyroid. 2018 Sep;28(9):1083-1093
pubmed: 30105931
Eur J Cardiothorac Surg. 2008 Oct;34(4):892-7
pubmed: 18722132
Endocr Relat Cancer. 2011 Jan 13;18(1):159-69
pubmed: 21118976
Clin Nucl Med. 2016 Apr;41(4):331-2
pubmed: 26646999
Head Neck. 2011 Apr;33(4):562-5
pubmed: 20665734
Clin Nucl Med. 2015 Aug;40(8):e417-9
pubmed: 26053727
Acta Radiol. 2016 Oct;57(10):1193-200
pubmed: 26163534
Endocr Pract. 2010 May-Jun;16(3):468-75
pubmed: 20551008
J Otolaryngol Head Neck Surg. 2013 Sep 01;42:38
pubmed: 24228840
Semin Nucl Med. 2011 Mar;41(2):121-38
pubmed: 21272686
Thyroid. 2002 Feb;12(2):155-61
pubmed: 11916285
Endocrine. 2019 Mar;63(3):531-536
pubmed: 30594973
Thyroid. 1997 Apr;7(2):273-6
pubmed: 9133699

Auteurs

Arnoldo Piccardo (A)

Department of Nuclear Medicine, Galliera Hospital, E.O. Ospedali Galliera, Mura delle Cappuccine 14, 16128, Genoa, Italy. arnoldo.piccardo@galliera.it.

Pierpaolo Trimboli (P)

Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Lugano, Bellinzona, Switzerland.

Luca Foppiani (L)

Department of Internal Medicine, Galliera Hospital, Genoa, Italy.

Giorgio Treglia (G)

Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Lugano, Bellinzona, Switzerland.
Health Technology Assessment Unit, General Directorate, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, Lausanne, Switzerland.

Giulia Ferrarazzo (G)

Department of Nuclear Medicine, Galliera Hospital, E.O. Ospedali Galliera, Mura delle Cappuccine 14, 16128, Genoa, Italy.

Michela Massollo (M)

Department of Nuclear Medicine, Galliera Hospital, E.O. Ospedali Galliera, Mura delle Cappuccine 14, 16128, Genoa, Italy.

Gianluca Bottoni (G)

Department of Nuclear Medicine, Galliera Hospital, E.O. Ospedali Galliera, Mura delle Cappuccine 14, 16128, Genoa, Italy.

Luca Giovanella (L)

Clinic of Nuclear Medicine and Molecular Imaging, Imaging Institute of Southern Switzerland, Lugano, Bellinzona, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH